PolymarketComprobar disponibilidadSin KYC2% de comisiónDatos de resolución verificadosBien calibradoProbabilidad implícita actual
December 50%-0.5pt
Calidad del mercado
30 / 100
Baja calidadVolumen 24h
237,9 €
Liquidez
135 €
Baja liquidezCompra / Venta
14.0% / 85.0%
Spread
71.0 pt
Spread amplioComentarios
0
Cambio 7d
-2.0 pts
Datos de mercado
Actualizado hace 6 minutos
23 jun 26, 2:13 UTC1 ene 27, 4:59 UTC
Tendencias
0%
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
When will the FDA reclassify BPC-157 to Category 1?
KalshiWhat will Trump say during his announcement on healthcare?
KalshiHeidi Overton confirmed as FDA Commissioner by which date?
PolymarketWill the ACA premium tax credits be extended?
KalshiWill hemp-derived CBN sleep products still be federally legal as “hemp” on Nov 12, 2026?
Manifold MarketsWill Anthony Fauci be arrested before 2029?
Manifold MarketsReglas
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET.
- Otherwise, this market will resolve to “No”.
- A qualifying announcement must be official and public.
- Any rumored or private statements of intention will not qualify.
- Any announcement that the drug has been reclassified to Category 1 will qualify.
- Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date.